Learn more

COLETICA

Overview
  • Total Patents
    220
About

COLETICA has a total of 220 patent applications. Its first patent ever was published in 1988. It filed its patents most often in France, United States and Japan. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and machines are BASF BEAUTY CARE SOLUTIONS FRANCE S A S, BASF BEAUTY CARE SOLUTIONS FRANCE SAS and ENGELHARD LYON.

Patent filings per year

Chart showing COLETICAs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Perrier Eric 147
#2 Huc Alain 68
#3 Andre Valerie 41
#4 Rival Delphine 30
#5 Levy Marie-Christine 24
#6 Buffevant Chantal 24
#7 Orly Isabelle 21
#8 Abdul Malak Nabil 20
#9 Bonnet Isabelle 19
#10 Reymermier Corinne 17

Latest patents

Publication Filing date Title
FR2884250A1 Use of aurones for the depigmenting or inhibiting activity of melanogenesis in cosmetic or dermatological compositions
FR2883749A1 Use of vegetable extracts for tinting skin according to its phototype
FR2863893A1 Use of active principles stimulating human beta-defensins type 2 and / or type 3
KR20040077827A A method for testing a substance which is potentially active in the field of lipolysis and its mainly cosmetic use
JP2005350436A Induction of activity of lysyl oxidase isoform for dealing with symptom attributable to insufficiency, deletion or disorder of elastic fiber formation
JP2005350435A Synthesis of loxl (lysyl oxidase-like) isoform for stimulating formation of elastic fiber and stimulation of activity
GB0413005D0 Ligand
US2004241129A1 Amphiphilic complexes, method for their preparation and compositions containing them
KR20040030732A A composition containing an extract of liana Uncaria tomentosa as one of the active ingredients for lipolysis
FR2859102A1 Use of a rhodiola crenulata extract by topic
FR2855968A1 Stimulation of the synthesis and activity of a lysyl oxidase-like loxl isoform to stimulate the formation of elastic fibers
FR2855969A1 Stimulation of the activity of a lysyl oxidase isoform to fight certain pathologies due to an incomplete, absent or disorganized elastogenesis
US2004096925A1 Method of testing the activity of a potentially active substance to inhibit the enzymatic activity of phospholipase A2
US2004096816A1 Method of indentifying an eventual modification of at least one biological parameter implementing young and aged living cells
US2004002055A1 Support with collagen base for tissue engineering and manufacture of biomaterials
FR2848854A1 PARTICLES COMPRISING A BIOPOLYMER DEGRADABLE UNDER THE EFFECT OF AN ELECTROMAGNETIC WAVE AS EMITTED BY SOLAR RADIATION
FR2848847A1 COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION COMPRISING AN AQUEOUS INSOLUBLE ENZYME AND USES THEREOF
FR2847268A1 Method for identifying an eventually modification of at least one biological parameter using living cells subject to stress and living cells not subject to this same stress
FR2843125A1 Active principles stimulating human beta-defensive type 2 and / or type 3, and cosmetic or pharmaceutical compositions comprising such active ingredients
FR2833271A1 PRODUCTION OF IN VITRO DENDRITIC CELLS FROM CD14 + MONOCYTES, IN PARTICULAR FOR THE PRODUCTION OF CELLULAR AND / OR TISSUE MODELS IN SUSPENSION, IN MONOLAYERS AND THREE-DIMENSIONAL; USE OF THESE MODELS